Achievements
-
.1stnew medicine
for the radical cure of relapsing P. vivax malaria in more than 60 years, approved by the US FDA and Australian TGA
-
.150active partners
working to help defeat malaria – part of an overall network of 400 partners in 50 countries
-
.96mcourses of SMC
delivered to 13 countries in 2019, enough to protect more than 20 million children
Defeating malaria together
Featured resources
-
COVID Box
160 different drugs or compounds with known or predicted activity against SARS-COV2 and other coronaviruses, available free of charge.
Aug 2020 -
MMV At a glance
The MMV at a glance highlights our unique partnership model, the growth of our portfolio and the increasing impact of our access work.
Jun 2020 -
Next-generation researchers: in malaria and beyond
Next-generation researchers in malaria and other neglected diseases discuss their work and aspirations.
Jun 2020
